
|Videos|April 8, 2021
Front Line Maintenance Options in Advanced Ovarian Cancer
Author(s)Rebecca Previs, MD
An expert oncologist reviews therapeutic options for front line maintenance in advanced ovarian cancer.
Advertisement
Advertisement
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves RP1/Nivolumab for Progression on Anti–PD-1 Therapy in Melanoma
2
Developers Initiate Phase 2/3 Ivonescimab/EV Trial in Bladder Cancer
3
The Lowest-Ever Hazard Ratio in Multiple Myeloma Bispecific Trials?
4
Why Earlier CAR T-Cell Therapy May Benefit Patients With Multiple Myeloma
5






























































